Re: Marching on to March events
|
3
|
Resverlogix Corp.
|
Feb 15, 2018 02:58PM
|
Re: Market Woes
|
2
|
Resverlogix Corp.
|
May 01, 2022 07:36AM
|
Re: May thru October 2020
|
9
|
Resverlogix Corp.
|
Apr 22, 2020 06:30AM
|
Re: MD&A out
|
4
|
Resverlogix Corp.
|
Dec 14, 2018 11:35AM
|
Re: MD&A out
|
2
|
Resverlogix Corp.
|
Dec 14, 2018 01:55PM
|
Re: MD&A out
|
3
|
Resverlogix Corp.
|
Dec 14, 2018 09:21PM
|
Re: MD&A out
|
6
|
Resverlogix Corp.
|
Dec 15, 2018 08:44AM
|
Re: MD&A out
|
3
|
Resverlogix Corp.
|
Dec 15, 2018 06:38PM
|
Re: Meanwhile...back at the outhouse :-)
|
3
|
Resverlogix Corp.
|
Sep 15, 2015 03:55PM
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
2
|
Zenith Epigenetics
|
Jan 27, 2023 02:17PM
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
3
|
Zenith Epigenetics
|
Jan 26, 2023 11:26AM
|
Re: Merrill Lynch
|
6
|
Resverlogix Corp.
|
Jun 09, 2020 04:46PM
|
Re: Micheal Sweeney
|
4
|
Resverlogix Corp.
|
Apr 11, 2016 07:56PM
|
Re: Micheal Sweeney ( disgruntled employee) ...
|
3
|
Resverlogix Corp.
|
Apr 07, 2016 08:35PM
|
Re: Micheal Sweeney is a fine fellow
|
7
|
Resverlogix Corp.
|
Apr 10, 2016 10:44AM
|
Re: Monday
|
6
|
Resverlogix Corp.
|
Oct 01, 2020 10:21PM
|
Re: Monday Tuesday Wednesday.....
|
4
|
Resverlogix Corp.
|
Sep 26, 2015 07:36AM
|
Re: More Exempt Distribution Investments
|
4
|
Zenith Epigenetics
|
Feb 29, 2024 10:38AM
|
Re: More volume than usual this early in the trading day....
|
3
|
Resverlogix Corp.
|
Mar 08, 2016 08:20PM
|
Re: More volume than usual this early in the trading day....
|
4
|
Resverlogix Corp.
|
Mar 07, 2016 06:12PM
|